TopFunds

Sartorius AG

XETRA: SRT.DE

Stock price

197.2 EUR

(-69.94%) 5 years

healthcareMedical - Instruments & Supplies

Insider Transactions

5Y price score: (96)
Help

The price score is a basic measure of the stock's performance against the S&P 500 Index over a five-year period.

A score of 100 indicates that the stock did as well as the S&P 500 Index.

A score below 100 means the stock underperformed the index, while a score above 100 means it outperformed the S&P 500.

5Y return: -69.94%
DATE RANGE:
EUR PER SHARE

  • Stock price
  • Sales
  • Purchases
  • Stock awards

Transaction History

Trade log
No insider transactions available.

156.4

52-week range

208.0

197.2

Your model inputs

Required return / cost of capital
%
FCFF terminal growth rate
%

Your fair value & Margin of safety

To calculate fair value based on cost of capital and terminal growth assumptions above, please select free cash flow forecast.

Forecast:

Set price notification

Valuation

Free Cash Flow Yield

Help
FCF Yield TTM = Trailing Twelve Months free cash flow per share / current market price per shareLearn more

2.2 %

Dividend Yield TTM

0.3 %

Market cap

$ 16,771

Price / Earnings TTM

Help
P/E TTM = current market price per share / Trailing Twelve Months diluted earnings per shareLearn more

69.7

Price / Book TTM

6

PEG TTM

Help
Price/Earnings-to-Growth ratio = P/E TTM divided by most recent annual diluted earnings per share growth rateLearn more

0.8

Earnings growth and return

LTM

5YR

10YR

Total return (price & dividends)

13.6 %

(69.2) %

171.7 %

Free cash flow per share growth

42.3 %

(21.8) %

1,418.5 %

Earnings per share growth

102.1 %

(52.3) %

21.1 %

Dividends

Previous dividend:0.73 per share, Paid, Ex-div date Mar 30, 2026

Analyst ratings

Buy

0

Hold

2

Sell

0

Financials

all figures in EUR Millions except per share data

Periods:

View:

Forecast:

Help

Averages

based on historical growth rates (CAGR) and average margins for last 10 or max, available and up to 10 years.

Analysts

Average Revenue and Net Income forecast estimates from analysts who cover the stock.

Custom

you can edit default forecast based on averages or analysts consensus and use it to calculate fair value based on your assumptions.

ㅤ

Actual
10 year gagr
Estimated
Projected
Fiscal
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Average (A)
2026
2027
2028
2029
2030
Terminal
FISCAL PERIOD END DATES
SHOW FORECAST VS ACTUAL
01Earnings per share
Help
Diluted EPSLearn more
1.9
1.5
1.7
2.1
3.2
4.7
6.2
13.4
3
1.2
2.2
1.9%
5.7
6.4
7.2
8
9
9.3
02FCF per share
0.2
0.3
0.1
0.2
2.2
4
6.7
3.1
4.3
8.2
3.1
31.3%
3.8
4
4.3
4.6
4.9
3.5
03Dividends per share
Help
Adjusted for splitsLearn more
0.3
0.4
0.5
0.5
0.6
0.4
0.7
1.3
1.4
0.7
0.7
10.7%
-
-
-
-
-
-
04Dividends payout, %
14.4%
33.6%
27.1%
24.4%
19.2%
7.6%
11.3%
9.4%
47.9%
60.4%
32.7%
8.5%
-
-
-
-
-
-
05Revenue
$ 1,115
$ 1,300
$ 1,405
$ 1,566
$ 1,827
$ 2,336
$ 3,449
$ 4,175
$ 3,396
$ 3,381
$ 3,538
12.2%
$ 3,971
$ 4,458
$ 5,003
$ 5,616
$ 6,303
$ 6,492
06ㅤ% Change
-
16.6%
8%
11.5%
16.7%
27.8%
47.7%
21%
(18.7)%
(0.4)%
4.7%
12.2%
12.2%
12.2%
12.2%
12.2%
12.2%
12.2%
07Net Income
126.3
102.9
114.7
141.3
218.7
321.5
427
913.1
205.2
84
154.9
2.1%
394.7
443
497.3
558.2
626.5
645.3
08ㅤ% Margin
11.3%
7.9%
8.2%
9%
12%
13.8%
12.4%
21.9%
6%
2.5%
4.4%
9.9% A
9.9%
9.9%
9.9%
9.9%
9.9%
9.9%
09CFO
125.4
170.4
206.5
244.5
377.2
511.5
865.8
734.2
853.6
976.2
656
18%
767
860.9
966.3
1,085
1,217
1,254
10ㅤ% Of revenue
11.3%
13.1%
14.7%
15.6%
20.7%
21.9%
25.1%
17.6%
25.1%
28.9%
18.5%
19.3% A
19.3%
19.3%
19.3%
19.3%
19.3%
19.3%
11CAPEX
(111.4)
(148.8)
(197.1)
(233.2)
(225.6)
(240.3)
(407.2)
(522.6)
(559.7)
(409.9)
(441.9)
14.8%
(507.2)
(582.1)
(668.1)
(766.7)
(880)
(1,010)
12ㅤ% Change
-
33.5%
32.5%
18.3%
(3.3)%
6.5%
69.5%
28.4%
7.1%
(26.8)%
7.8%
14.8% A
14.8%
14.8%
14.8%
14.8%
14.8%
14.8%
13FCFF
Help
Free Cash Flow to the Firm = Cash Flows from Operating Activities (09) – Capital Expenditures (11)Learn more
13.9
21.7
9.4
11.3
151.6
271.3
458.6
211.6
293.9
566.3
214.1
31.4%
259.9
278.9
298.3
317.9
337.5
244
14Total assets
1,437
1,753
2,298
2,527
2,844
4,697
5,698
6,978
9,755
10,103
9,717
21.1%
11,764
14,241
17,240
20,871
25,267
30,588
15ㅤ% Change
-
22%
31.1%
10%
12.6%
65.2%
21.3%
22.5%
39.8%
3.6%
(3.8)%
21.1%
21.1%
21.1%
21.1%
21.1%
21.1%
21.1%
16Total liabilities
792.5
1,016
1,491
1,554
1,763
3,295
3,978
4,319
6,998
6,205
5,850
22.1%
7,082
8,573
10,379
12,565
15,211
18,414
17ㅤ% Of assets
55.1%
58%
64.9%
61.5%
62%
70.2%
69.8%
61.9%
71.7%
61.4%
60.2%
60.2% A
60.2%
60.2%
60.2%
60.2%
60.2%
60.2%
18Shareholders Equity
644.8
736.8
806.6
973.4
1,081
1,402
1,720
2,659
2,757
3,898
3,867
19.6%
4,682
5,668
6,861
8,306
10,056
12,174
19Net Debt
344
485.9
895.5
959.5
1,011
1,884
1,733
2,375
4,932
3,746
3,741
27%
-
-
-
-
-
-
20Shares Outstanding
Help
Diluted Weighted-average Shares OutstandingLearn more
68,195
68,388
68,388
68,388
68,388
68,416
68,416
68,416
68,416
68,975
69,045
0.1%
69,131
69,217
69,302
69,388
69,474
69,561
21ㅤ% Change
-
0.3%
-
-
-
-
-
-
-
0.8%
0.1%
0.1%
0.1%
0.1%
0.1%
0.1%
0.1%
0.1%
22ROA
8.8%
5.9%
5%
5.6%
7.7%
6.8%
7.5%
13.1%
2.1%
0.8%
1.6%
-
3.4%
3.1%
2.9%
2.7%
2.5%
2.1%
23ROE
19.6%
14%
14.2%
14.5%
20.2%
22.9%
24.8%
34.3%
7.4%
2.2%
4%
-
8.4%
7.8%
7.3%
6.7%
6.2%
5.3%
24Interest coverage
21.8
14.2
9.9
12
12.8
9.1
16.2
16.7
3.5
2.1
3.3
-
-
-
-
-
-
-
25Dividend Yield
0.4%
0.7%
0.6%
0.5%
0.3%
0.1%
0.1%
0.3%
0.4%
0.3%
0.3%
-
-
-
-
-
-
-
26P/E Ratio
32.5
47
48
52.8
59.6
73.1
95.4
27.7
115.1
176.4
110.4
-
-
-
-
-
-
-
27Stock price range
25-78
54-87
66-89
77-139
93-176
156-362
329-827
264-489
181-373
168-288
146-226
-
-
-
-
-
-
-
28Market Cap
Help
End of Period Market CapLearn more
4,099
4,821
5,481
7,475
13,049
23,508
40,721
25,273
23,624
14,844
17,068
15.3%
701.3
1,029
1,390
1,788
2,224
-
29FCF Yield
0.3%
0.5%
0.2%
0.2%
1.2%
1.2%
1.1%
0.8%
1.2%
3.8%
1.3%
14%
37.1%
27.1%
21.5%
17.8%
15.2%
-
30Average stock price
51.6
70.7
77.7
107.9
134.3
259.3
578
376.5
277.2
228
185.9
13.7%
10.1
14.9
20.1
25.8
32
-
31 CEO
JK
Dr. Joachim Kreuzburg
MG
Michael Grosse